Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed reliable models to predict how well certain compounds bind to androgen receptors, emphasizing the importance of atomic electronegativity.

New progesterone-based compounds can block male hormones.

New steroids were patented as effective for treating acne, hair loss, and other conditions related to hormones.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Synthetic 19-norprogestins promote bone cell growth and function through their non-phenolic metabolites.

CB-03-04 shows promise as a treatment for prostate issues due to its strong anti-androgen effects.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

New curcumin analogues help fight prostate cancer by breaking down androgen receptors.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

A new treatment for hair loss shows promise with fewer side effects.

New testosterone analogs show promise for male contraception with better activity and potentially fewer side effects.

Androgen receptor activity is influenced by hormones, co-factors, modifications, and mutations.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Stiripentol shows promise as a potential treatment for androgen-related diseases but needs more testing.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

3-tetrazolo steroidal analogs can strongly inhibit the enzyme linked to hair loss.

Targeting androgen receptors with antiandrogen oligonucleotides could effectively treat hair loss.

Spironolactone reduces the number of androgen receptor sites in rat skin by blocking them with its metabolite.

Testosterone increases 3α-androstanediol levels, which can be blocked by finasteride.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.

Anti-androgen drugs can treat conditions like prostate cancer and male pattern baldness by blocking effects of testosterone and DHT.

Glucocorticoids reduce fat production in liver cells, while androgens increase it in females; manipulating certain enzymes can influence these effects.

Activating androgen receptors in muscle can increase muscle mass and reduce fat.